Table 2.
Baseline characteristics of study participants.
| Control group (n = 21) | Treatment group (n = 22) | |
|---|---|---|
| Age, y | 62.8 ± 6.3 | 67.0 ± 8.1 |
| Male sex, n (%) | 6 (28.6) | 10 (45.5) |
| Body mass index, kg/m2 | 24.7 ± 2.9 | 26.9 ± 6.1 |
| Statins, n (%) | 15 (71.4) | 15 (68.2) |
| Myocardial infarction history, n (%) | 3 (14.3) | 5 (22.7) |
| Hypertension, n (%) | 14 (66.7) | 18 (81.8) |
| Dyslipidemia, n (%) | 16 (76.2) | 16 (72.2) |
| Diabetes, n (%) | 10 (47.6) | 11 (50) |
| rs5787 GG, n (%) | 21 (100) | 22 (100) |
| rs5911 AA/(AC + CC) | 5/16 | 6/16 |
| rs3842788 GG, n (%) | 21 (100) | 22 (100) |